ARMC
TMO icon

American Research & Management Company’s Thermo Fisher Scientific TMO Stock Holding History

American Research & Management Company’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.12M Buy
4,172
+289
+7% +$162K 0.58% 51
2022
Q2 		$2.11M Buy
3,883
+646
+20% +$356K 0.54% 54
2022
Q1 		$1.91M Buy
3,237
+75
+2% +$43.1K 0.42% 58
2021
Q4 		$2.11M Sell
3,162
-30
-0.9% -$18.7K 0.46% 54
2021
Q3 		$1.82M Buy
3,192
+47
+1% +$25.8K 0.42% 56
2021
Q2 		$1.59M Buy
3,145
+151
+5% +$71.2K 0.36% 58
2021
Q1 		$1.37M Sell
2,994
-12
-0.4% -$5.73K 0.33% 64
2020
Q4 		$1.4M Buy
3,006
+48
+2% +$22.5K 0.36% 62
2020
Q3 		$1.31M Buy
2,958
+36
+1% +$14.9K 0.38% 60
2020
Q2 		$1.06M Buy
2,922
+7
+0.2% +$2.35K 0.32% 63
2020
Q1 		$827K Sell
2,915
-50
-2% -$15.8K 0.31% 67
2019
Q4 		$963K Hold
2,965
– – 0.29% 69
2019
Q3 		$864K Hold
2,965
– – 0.26% 76
2019
Q2 		$871K Hold
2,965
– – 0.26% 79
2019
Q1 		$812K Hold
2,965
– – 0.23% 84
2018
Q4 		$664K Hold
2,965
– – 0.22% 84
2018
Q3 		$724K Hold
2,965
– – 0.21% 86
2018
Q2 		$614K Hold
2,965
– – 0.21% 81
2018
Q1 		$612K Sell
2,965
-25
-0.8% -$5.25K 0.2% 81
2017
Q4 		$568K Hold
2,990
– – 0.18% 89
2017
Q3 		$566K Hold
2,990
– – 0.18% 83
2017
Q2 		$522K Buy
2,990
+200
+7% +$33.6K 0.17% 85
2017
Q1 		$429K Buy
2,790
+200
+8% +$30.6K 0.15% 81
2016
Q4 		$365K Buy
2,590
+1,950
+305% +$287K 0.13% 91
2016
Q3 		$102K Buy
640
+540
+540% +$83.2K 0.04% 134
2016
Q2 		$15K Buy
100
+50
+100% +$7.38K 0.01% 245
2016
Q1 		$7K Hold
50
– – ﹤0.01% 290
2015
Q4 		$7K Hold
50
– – ﹤0.01% 291
2015
Q3 		$6K Hold
50
– – ﹤0.01% 310
2015
Q2 		$6K Buy
+50
New +$6.52K ﹤0.01% 321

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Research & Management Company's TMO Position: Q3 2022 in Review

American Research & Management Company increased its Thermo Fisher Scientific (TMO) stake by 7.4% in Q3 2022, buying an estimated $162K and bringing the position to 4,172 shares worth $2.12M. The position accounts for 0.58% of the portfolio, ranked #51.

American Research & Management Company first reported a position in TMO in Q2 2015 and has held it in 30 quarters since. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • American Research & Management Company held 4,172 shares of Thermo Fisher Scientific worth $2.12M as of Q3 2022.
  • American Research & Management Company bought 289 Thermo Fisher Scientific shares in Q3 2022, an estimated $162K.
  • Thermo Fisher Scientific made up 0.58% of American Research & Management Company's portfolio in Q3 2022, its #51 holding.
  • American Research & Management Company first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 30 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.